The major source of alanine aminotransferase (ALT) is the liver with elevated ALT found in patients with hepatitis, cirrhosis, obstructive jaundice, carcinoma of the liver, or chronic alcohol abuse. ALT is more liver specific than AST and ALT elevations persist for longer periods of time. ALT is included as the standard hepatocellular enzyme measured in the laboratory set of tests for liver function (LIV) and profile (PRO) instead of AST.
ALT is present to a lesser extent in a variety of other tissues that includes skeletal muscle, kidney and heart. ALT is only slightly elevated in patients who have an uncomplicated myocardial infarction. In patients with vitamin B6 activity ALT may be decreased.
No special patient preparation required.
Adult male and female reference range: 0-55 IU/L (Abbott Alinity)
UK NEQAS for Clinical Chemistry Scheme
Copyright UHB Pathology 2018
Protection of Personal Information – Clinical Laboratory Services comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.
University Hospitals Birmingham medical laboratories at Queen Elizabeth Hospital, Heartlands Hospital, Good Hope Hospital and Solihull Hospital are UKAS (United Kingdom Accreditation Service) accredited to the ISO 15189:2012 standard. For a list of accredited tests and other information please visit the UKAS website using the following link: https://www.ukas.com/find-an-organisation/
Tests not appearing on the UKAS Schedule of Accreditation currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.
For further test information, please visit the test database: http://qehbpathology.uk/test-database
For further information contact Louise Fallon, Quality Manager, 0121 371 5962